HighTower Advisors LLC Sells 199,796 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

HighTower Advisors LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 58.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 141,874 shares of the company’s stock after selling 199,796 shares during the period. HighTower Advisors LLC’s holdings in GE HealthCare Technologies were worth $11,092,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of GEHC. D1 Capital Partners L.P. acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $268,159,000. Van ECK Associates Corp increased its position in shares of GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after purchasing an additional 2,506,417 shares during the last quarter. State Street Corp increased its position in shares of GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after purchasing an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $93,713,000. Finally, Jennison Associates LLC increased its position in shares of GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after purchasing an additional 948,017 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $81.97 on Monday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The stock’s fifty day moving average price is $87.26 and its two-hundred day moving average price is $86.13. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The firm has a market cap of $37.48 billion, a price-to-earnings ratio of 18.93, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.